T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea
· Delayed Price · Currency is KRW
4,560.00
-70.00 (-1.51%)
May 14, 2025, 11:26 AM KST
T&R Biofab Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Operating Revenue | 4,874 | 5,199 |
| Other Revenue | - | -0 |
| Revenue | 4,874 | 5,199 |
| Revenue Growth (YoY) | -6.26% | - |
| Cost of Revenue | 2,766 | 4,151 |
| Gross Profit | 2,108 | 1,048 |
| Selling, General & Admin | 7,230 | 7,024 |
| Research & Development | 5,510 | 4,399 |
| Other Operating Expenses | 172.15 | 227.69 |
| Operating Expenses | 15,407 | 13,902 |
| Operating Income | -13,299 | -12,853 |
| Interest Expense | -2.2 | -3.24 |
| Interest & Investment Income | 1,227 | 1,676 |
| Currency Exchange Gain (Loss) | 7.49 | 0.97 |
| Other Non Operating Income (Expenses) | 8,044 | -1,424 |
| EBT Excluding Unusual Items | -4,023 | -12,604 |
| Gain (Loss) on Sale of Investments | -517.37 | 5.26 |
| Gain (Loss) on Sale of Assets | -5.8 | -0.14 |
| Asset Writedown | - | -195.49 |
| Other Unusual Items | -3,133 | -625.01 |
| Pretax Income | -7,679 | -13,419 |
| Net Income | -7,679 | -13,419 |
| Net Income to Common | -7,679 | -13,419 |
| Shares Outstanding (Basic) | 22 | 21 |
| Shares Outstanding (Diluted) | 22 | 21 |
| Shares Change (YoY) | 1.59% | - |
| EPS (Basic) | -356.48 | -632.85 |
| EPS (Diluted) | -356.48 | -632.85 |
| Free Cash Flow | -14,309 | -19,456 |
| Free Cash Flow Per Share | -664.29 | -917.58 |
| Gross Margin | 43.24% | 20.16% |
| Operating Margin | -272.87% | -247.22% |
| Profit Margin | -157.56% | -258.10% |
| Free Cash Flow Margin | -293.60% | -374.22% |
| EBITDA | -10,895 | -10,697 |
| EBITDA Margin | -223.55% | -205.74% |
| D&A For EBITDA | 2,404 | 2,156 |
| EBIT | -13,299 | -12,853 |
| EBIT Margin | -272.87% | -247.22% |
| Advertising Expenses | 390.07 | 267.47 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.